|
|
|||
|
||||
OverviewDetails how the research backing the increasing number of medical products that Americans rely upon has been impacted by widespread industry influence and public policy failure. Industry controls the agenda and conduct for the vast majority of medical research in the U.S., biasing the information available to doctors, patients, and policymakers so that they disproportionately reflect the interests of pharmaceutical and medical device companies. While it is important for a stable society that the general public trusts the institutions which guard their health, it is vital that such institutions are worthy of trust. Thus, this book examines the current state of medical knowledge to determine the question facing Americans: should we trust our medical and public health institutions? Unreliable exposes how pharmaceutical and medical device companies have impacted the American healthcare system, making doctors and patients alike rely on untrustworthy information. This influence involves opaqueness and poor practices in clinical trials, financial ties to key medical institutions, and the regulatory capture of the FDA. This book provides concrete, specific policy solutions to empower Americans to trust public health and medical institutions. Full Product DetailsAuthor: Brandon Novick (Center for Economic and Policy Research, USA)Publisher: Bloomsbury Publishing Plc Imprint: Bloomsbury Academic Dimensions: Width: 14.80cm , Height: 2.20cm , Length: 22.60cm Weight: 0.600kg ISBN: 9798216373636Pages: 408 Publication Date: 12 November 2026 Audience: College/higher education , Professional and scholarly , Tertiary & Higher Education , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Not yet available This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of ContentsIntroduction Chapter 1: Industry Control Chapter 2: Less Opaque is Still Opaque Chapter 3: False Prophets and the Role of Medical Journals Chapter 4: Poor Instructors and Clinical Practice Guidelines Chapter 5: Faster Approvals and Weaker Evidence Chapter 6: It Gets Worse: Medical Devices Chapter 7: Regulatory Capture an Corruption of the FDA Chapter 8: Why Do Doctors Accept This? Chapter 9: The Root Incentive: Patents Chapter 10: The COVID Case Study Chapter 11: A Path Forward ConclusionReviewsAuthor InformationBrandon Novick is the policy coordinator at The Center for Economic and Policy Research, USA. He specializes in health policy research and educating federal policymakers. Tab Content 6Author Website:Countries AvailableAll regions |
||||